| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |